prilosec otc price pravachol where to buy Movers in Rayno Diagnostics and Tools Stocks

ponstel price without insurance On a lackluster day in the market two of our picks were up big,two others exceeded one year highs.

requip tablet price in pakistan avodart uk hair loss Illumina (ILMN $81) was up 10% on earnings to an all time high recovering from its downdraft in 2011. Revenues were up 23% from previous quarter in 2012 and GAAP income was $36 M or $0.26 per share. Free cash flow was $77M for Q2. Illumina raised their expectations for 2013.

shatavari churna price timoptic price Response Genetics (RGDX $2.13) was up 11% on huge volume of 563k shares with an average volume of 57k shares.There was no news so we can assume that a fund or an individual has added to their position. The Company has been in a turnaround mode with a recent financing and an emphasis on boosting sales of its predictive tests of  tumor response for various types of cancer. Revenues for the year are estimated at $22 M. Here is what we wrote on May 15,2013:

cost of relafen 500 mg Emerging Biomarker Companies Redux: Positioned For Growth – Seeking Alpha

indulekha oil price Also up today in the Rayno DX Portfolio are :

voveran gel price Alere ( bizol germany gmbh ALR $28.6) up 1.9% and a one year high.

proviron buy Sequenom ( cefaclor cost SQNM $4.68) up 3.66%

forzest buy Thermo Fisher ( liv 52 uk TMO $90.76) up 1.4% at an all time high

lyrica medicine cost We will be attending the AACC (American Association of Clinical Chemistry) Meeting in Houston next week and will provide an update on many of our focus stocks.

cifran ear drops price  

exforge uk price  

tretiva 20 price  

 

Pin It on Pinterest